Taku Fujimura

Taku Fujimura

Sendai, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 289 publications

Successful treatment of multiple phototherapy-induced cutaneous squamous cell carcinomas with nivolumab monotherapy.

Successful treatment of multiple phototherapy-induced cutaneous squamous cell carcinomas with nivolumab monotherapy.

Journal: European journal of dermatology : EJD
Published: August 28, 2026

Streptococcus-Associated Erythema Multiforme Major With Acute Generalized Pustular Bacterid-Like Subcorneal Pustulation.

Streptococcus-Associated Erythema Multiforme Major With Acute Generalized Pustular Bacterid-Like Subcorneal Pustulation.

Journal: The Journal of dermatology
Published: May 08, 2026

Cutaneous Squamous Cell Carcinoma Arising From Hidradenitis Suppurativa and Epidermal Cyst: Clinical Characteristics, Baseline Neutrophil-To-Lymphocyte Ratio, and Disease-Specific Survival in a Retrospective Cohort.

Cutaneous Squamous Cell Carcinoma Arising From Hidradenitis Suppurativa and Epidermal Cyst: Clinical Characteristics, Baseline Neutrophil-To-Lymphocyte Ratio, and Disease-Specific Survival in a Retrospective Cohort.

Journal: The Journal of dermatology
Published: May 02, 2026

Clinical utility of comprehensive genomic profiling in 175 Japanese patients with advanced skin malignancies refractory to standard therapies.

Clinical utility of comprehensive genomic profiling in 175 Japanese patients with advanced skin malignancies refractory to standard therapies.

Journal: JAAD international
Published: March 09, 2026

Hypopigmented Mycosis Fungoides With Childhood-Onset and Middle-Aged Onset: Two Case Reports Focusing on the Cutaneous Immune Microenvironment.

Hypopigmented Mycosis Fungoides With Childhood-Onset and Middle-Aged Onset: Two Case Reports Focusing on the Cutaneous Immune Microenvironment.

Journal: The Journal of dermatology
Published: February 05, 2026

Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1).

Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1).

Journal: BMC cancer
Published: January 27, 2026

Successful Control of Langer hans Cell Sarcoma in a Super-Aged Patient Using Intensity-Modulated Radiotherapy.

Successful Control of Langer hans Cell Sarcoma in a Super-Aged Patient Using Intensity-Modulated Radiotherapy.

Journal: The Journal of dermatology
Published: December 27, 2025

The significance of tumor microenvironment for immunotherapy in melanoma and non-melanoma skin cancer.

The significance of tumor microenvironment for immunotherapy in melanoma and non-melanoma skin cancer.

Journal: Immunological medicine
Published: August 25, 2025

Plasminogen Activator Inhibitor-1 in Skin Malignancies: Therapeutic Implications of Its Inhibition.

Plasminogen Activator Inhibitor-1 in Skin Malignancies: Therapeutic Implications of Its Inhibition.

Journal: Biomolecules
Published: August 13, 2025

Three Cases of Advanced Melanoma With Severe irAE Colitis With Rapid Tumor Progression Following Infliximab Administration.

Three Cases of Advanced Melanoma With Severe irAE Colitis With Rapid Tumor Progression Following Infliximab Administration.

Journal: The Journal of dermatology
Published: August 09, 2025

PAI-1 in Skin Malignancies: a Central Regulator of Tumor Progression and Therapeutic Resistance.

PAI-1 in Skin Malignancies: a Central Regulator of Tumor Progression and Therapeutic Resistance.

Journal: Current treatment options in oncology
Published: July 12, 2025

An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients with Adult T-Cell Leukemia/Lymphoma.

An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients with Adult T-Cell Leukemia/Lymphoma.

Journal: The Journal of dermatology
Published: July 12, 2025
Showing 1-12 of 289

Last Updated: 09/26/2026